<VariationArchive VariationID="497358" VariationName="NM_004482.4(GALNT3):c.892del (p.Tyr298fs)" VariationType="Deletion" Accession="VCV000497358" Version="10" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-23" DateCreated="2018-04-02" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="488782" VariationID="497358">
      <GeneList>
        <Gene Symbol="GALNT3" FullName="polypeptide N-acetylgalactosaminyltransferase 3" GeneID="2591" HGNC_ID="HGNC:4125" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165747588" stop="165794692" display_start="165747588" display_stop="165794692" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166604312" stop="166650802" display_start="166604312" display_stop="166650802" Strand="-" />
          </Location>
          <OMIM>601756</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004482.4(GALNT3):c.892del (p.Tyr298fs)</Name>
      <CanonicalSPDI>NC_000002.12:165759516:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165759517" stop="165759517" display_start="165759517" display_stop="165759517" variantLength="1" positionVCF="165759516" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166616027" stop="166616027" display_start="166616027" display_stop="166616027" variantLength="1" positionVCF="166616026" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Y298fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.166616027del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.166616027del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.165759517del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.165759517del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012069.1" sequenceAccession="NG_012069" sequenceVersion="1" change="g.39777del">
            <Expression>NG_012069.1:g.39777del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004482.4" sequenceAccession="NM_004482" sequenceVersion="4" change="c.892del" MANESelect="true">
            <Expression>NM_004482.4:c.892del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004473.2" sequenceAccession="NP_004473" sequenceVersion="2" change="p.Tyr298fs">
            <Expression>NP_004473.2:p.Tyr298fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA59748679" DB="ClinGen" />
        <XRef Type="rs" ID="762936774" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00004" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004482.4(GALNT3):c.892del (p.Tyr298fs) AND not provided" Accession="RCV000597952" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-19" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004482.4(GALNT3):c.892del (p.Tyr298fs) AND Tumoral calcinosis, hyperphosphatemic, familial, 1" Accession="RCV002272298" Version="4">
        <ClassifiedConditionList TraitSetID="2115">
          <ClassifiedCondition DB="MedGen" ID="C4692564">Tumoral calcinosis, hyperphosphatemic, familial, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-02-02" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-19" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-04-02" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15133511</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20358599</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27164190</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27867679</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GALNT3</URL>
        </Citation>
        <DescriptionHistory Dated="2022-08-04">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2115" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3922" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CALCINOSIS, TUMORAL, WITH HYPERPHOSPHATEMIA</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LIPOCALCINOGRANULOMATOSIS</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MORBUS TEUTSCHLAENDER</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TEUTSCHLAENDER DISEASE, FAMILIAL</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TUMORAL CALCINOSIS, PRIMARY HYPERPHOSPHATEMIC</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tumoral calcinosis, hyperphosphatemic, familial, 1</ElementValue>
                <XRef ID="MONDO:0100252" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperostosis-hyperphosphatemia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperostosis with hyperphosphatemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cortical hyperostosis with hyperphosphatemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HFTC</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HHS</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PHPTC</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HFTC1</ElementValue>
                <XRef Type="MIM" ID="211900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hyperphosphatemic familial tumoral calcinosis (HFTC) is characterized by: Ectopic calcifications (tumoral calcinosis) typically found in periarticular soft tissues exposed to repetitive trauma or prolonged pressure (e.g., hips, elbows, and shoulders); and Painful swellings (referred to as hyperostosis) in the areas overlying the diaphyses of the tibiae (and less often the ulna, metacarpal bones, and radius). The dental phenotype unique to HFTC includes enamel hypoplasia, short and bulbous roots, obliteration of pulp chambers and canals, and pulp stones. Less common are large and small vessel calcifications that are often asymptomatic incidental findings on radiologic studies but can also cause peripheral vascular insufficiency (e.g., pain, cold extremities, and decreased peripheral pulses). Less frequently reported findings include testicular microlithiasis and angioid streaks of the retina.</Attribute>
                <XRef ID="NBK476672" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15146" />
                <XRef ID="15146" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29389098</ID>
                <ID Source="BookShelf">NBK476672</ID>
              </Citation>
              <XRef ID="53715" DB="Orphanet" />
              <XRef ID="C4692564" DB="MedGen" />
              <XRef ID="MONDO:0100252" DB="MONDO" />
              <XRef Type="MIM" ID="211900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1374226" SubmissionDate="2018-09-19" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="54363_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000701824" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNT3" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="-" referenceAllele="A" start="166616027" stop="166616027" variantLength="1" />
            <GeneLocation>NM_004482.3:Ex5</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="762936774" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GALNT3</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5466412" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_004482.4:c.892del|OMIM:211900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002815014" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004482.4:c.892del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="211900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5978913" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="3436895|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003288445" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15133511</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20358599</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27164190</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr298Thrfs*5) in the GALNT3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GALNT3 are known to be pathogenic (PMID: 15133511, 20358599). This variant is present in population databases (rs762936774, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with tumoral calcinosis (PMID: 27164190). ClinVar contains an entry for this variant (Variation ID: 497358). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNT3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.166616027del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5003008" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_004482_3_GALNT3_c_892delT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002557202" DateUpdated="2024-07-23" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20358599</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27867679</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with hyperphosphatemic familial tumoral calcinosis 1 (MIM#211900). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0115 - Variants in this gene are known to have variable expressivity. Tumoral calcinosis (TC) and hyperostosis-hyperphosphatemia syndrome (HHS) are a continuous spectrum. TC is characterized by the presence of ectopic calcifications around major joints, whereas HHS is characterized by recurrent long bone lesions with hyperostosis (PMID: 20358599). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD &lt;0.01 for a recessive condition (v3: 3 heterozygotes, 0 homozygotes). (SP) 0701 - Other variants predicted to result in NMD comparable to the one identified in this case have very strong previous evidence for pathogenicity (PMID: 27867679, ClinVar, DECIPHER). (SP) 0803 - This variant has limited previous evidence of pathogenicity in unrelated individuals. It has been reported likely pathogenic in ClinVar and detected in a compound heterozygote individual with tumoral calcinosis (PMID: 27867679). (SP) 1205 - This variant has been shown to be maternally inherited (by segregation analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNT3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_14871</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004482.3:c.892delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="211900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_32</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5978913" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5466412" TraitType="Disease" MappingType="XRef" MappingValue="211900" MappingRef="OMIM">
        <MedGen CUI="C4692564" Name="Tumoral calcinosis, hyperphosphatemic, familial, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1374226" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5003008" TraitType="Disease" MappingType="XRef" MappingValue="211900" MappingRef="OMIM">
        <MedGen CUI="C4692564" Name="Tumoral calcinosis, hyperphosphatemic, familial, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

